Children get arthritis too; Data on a blood test to help characterize JIA and its subtypes.

Simran ChahalNews

At the world’s premier arthritis conference, the American College of Rheumatology Annual Meeting (ACR), taking place in San Diego on November 3rd-8th, leading investigators from the United States, Canada and Egypt will present new data on the 14-3-3η blood test. Several of these studies grow the body of evidence of 14-3-3η’s important role as an early diagnostic test that assists with rheumatoid arthritis patient management along the disease course. As a highlight of these new data are two studies describing how 14-3-3η testing can assist with arthritis diagnosis in children. Juvenile Idiopathic Arthritis (JIA) is an ambiguous disease, with several subtypes, that new blood tests like 14-3-3η can help better characterize. As a marker of joint damage progression risk, it is expected that 14-3-3η will have an increasingly important role in the management of multiple types of arthritis.

List of 14-3-3η ACR/ARHP 2017 Conference Proceedings

Title Date & Time
Evaluation of Synovial Fluid 14-3-3η Protein as a Marker of Joint Damage in Rheumatoid Arthritis Patients
Authors: Nevin Hammam, Shaimaa Salah, Anthony Marotta and Emad F. Kholef
Abstract Number: 1366		 November 6th, 9:00am
Poster Hall C
14-3-3η: Useful for More Than the Diagnosis of Rheumatoid Arthritis
Authors: Lisa Zickuhr, Maryam Pourpaki, Martha M. Brooks and Amy Joseph
Abstract Number: 1355		 November 6th, 9:00am
Poster Hall C
Prevalance of Serum 14-3-3η (eta) in Juvenile Idiopathic Arthritis
Authors: Iris Reyhan, Olga S. Zhukov, Robert J. Lagier, Robert Bridgforth, Gary J Williams, Joanna M. Popov, Stanley J. Naides and Andreas Reiff
Abstract Number: 2312		 November 7th, 9:00am
Poster Hall C
14-3-3η (eta) Protein in Juvenile Idiopathic Arthritis (JIA) Patients
Authors: Austin M. Dalrymple, Paul Tuttle IV, Lance Feller, Olga S. Zhukov, Robert J. Lagier, Robert Bridgforth, Gary J Williams, Joanna M. Popov, Stanley J. Naides and Terry Moore
Abstract Number 2327		 November 7th, 9:00am
Poster Hall C
For more information on 14-3-3η testing during the conference, please visit the following exhibit booths:
  • Labcorp: Booth No. 1034
  • Quest Diagnostics: Booth No. 2328
  • RDL Reference Laboratory: Booth No. 1939

The 14-3-3η blood test is available in the U.S through Labcorp, Quest Diagnosticsand RDL Reference Laboratory. JOINTstat™ (14-3-3η) is CE marked and TGA approved for clinical use in Europe and Australia. In Canada, the test is available through LifeLabs and in Japan through Medical & Biological Laboratories (MBL).

For more information on the 14-3-3η test and Augurex Life Sciences Corp, visit www.augurex.com or www.jointstat.com.